Literature DB >> 7607839

Coronary artery bypass surgery in the diabetic patient.

M Maher1, H P Singh, S Dias, J Street, T Aherne.   

Abstract

Coronary artery and peripheral occlusive arterial disease frequently complicate diabetes mellitus, with death due to atherosclerotic coronary artery disease being three times more likely in diabetic compared to non-diabetic patients. The profile of 32 diabetic patients and 32 matched controls who underwent coronary artery bypass (CABG) is studied and their early and late postoperative outcomes are described. The mean age was 61 +/- 1 year in both groups. The diabetic group comprised 26 non-insulin dependent and 6 insulin dependent diabetics, who had a mean duration of diabetes of 8.5 years (range 2 months--35 years). The median number of grafts per patient performed in the diabetic group and the control group was 3.5 and 3 respectively. There was no mortality in the series, however considerably greater wound morbidity rates were encountered in the diabetic group when compared to matched controls. One renal transplant patient in the diabetic group suffered irreversible acute tubular necrosis and became dialysis dependent post-operatively. Longterm follow-up showed no longterm mortality in either group, with full relief of angina achieved in 75% of diabetic patients compared with 87.5% of matched controls. In addition diabetic patients suffered greater longterm cardiac morbidity than the control group (21.8% versus 12.5%). The results of this study suggest that CABG is a safe operation for the diabetic patient. Diabetic patients receive satisfactory symptomatic relief of angina, but suffer increased perioperative wound complications and greater incidence of longterm cardiac morbidity.

Entities:  

Mesh:

Year:  1995        PMID: 7607839     DOI: 10.1007/BF02973280

Source DB:  PubMed          Journal:  Ir J Med Sci        ISSN: 0021-1265            Impact factor:   1.568


  14 in total

1.  Pretransplant coronary arteriography for diabetic renal transplant recipients.

Authors:  M I Lorber; C T Van Buren; S M Flechner; L Cameron; J Leatherwood; W E Walker; R W Smalling; B D Kahan
Journal:  Transplant Proc       Date:  1987-02       Impact factor: 1.066

2.  Factors associated with long-term survival of diabetics.

Authors:  S Pell; C A D'Alonzo
Journal:  JAMA       Date:  1970-12-07       Impact factor: 56.272

3.  Coronary artery disease in 100 diabetics with end-stage renal failure.

Authors:  W E Braun; D F Phillips; D G Vidt; A C Novick; S Nakamoto; K L Popowniak; E Paganini; M Magnusson; M Pohl; D R Steinmuller
Journal:  Transplant Proc       Date:  1984-06       Impact factor: 1.066

4.  Complications of coronary artery surgery in diabetic patients.

Authors:  R Fietsam; J Bassett; J L Glover
Journal:  Am Surg       Date:  1991-09       Impact factor: 0.688

5.  Influence of diabetes and mammary artery grafting on survival after coronary bypass.

Authors:  J J Morris; L R Smith; R H Jones; D D Glower; P B Morris; L H Muhlbaier; J G Reves; J S Rankin
Journal:  Circulation       Date:  1991-11       Impact factor: 29.690

6.  Myocardial revascularization in patients on renal replacement therapy.

Authors:  M De Meyer; W Wyns; R Dion; G Khoury; Y Pirson; C van Ypersele De Strihou
Journal:  Clin Nephrol       Date:  1991-09       Impact factor: 0.975

7.  Wound infection in cardiac surgery.

Authors:  H Shuhaiber; T Chugh; S Portoian-Shuhaiber; D Ghosh
Journal:  J Cardiovasc Surg (Torino)       Date:  1987 Mar-Apr       Impact factor: 1.888

8.  Coronary artery bypass surgery morbidity.

Authors:  P Kuan; S B Bernstein; M H Ellestad
Journal:  J Am Coll Cardiol       Date:  1984-06       Impact factor: 24.094

9.  Diabetes mellitus and coronary artery bypass. Short-term risk and long-term prognosis.

Authors:  N W Salomon; U S Page; J E Okies; J Stephens; A H Krause; J C Bigelow
Journal:  J Thorac Cardiovasc Surg       Date:  1983-02       Impact factor: 5.209

10.  Aortocoronary bypass in the diabetic patient.

Authors:  J J Verska; W J Walker
Journal:  Am J Cardiol       Date:  1975-06       Impact factor: 2.778

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.